• Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Therapy

  • Apr 22 2025
  • Length: 40 mins
  • Podcast

Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Therapy

Listen for free

View show details

  • Summary

  • Featuring a slide presentation from Dr Matthew Matasar and related discussion from Dr Carla Casulo, Dr Matasar and Dr Laurie H Sehn, including the following topics:

    • Overview of Bispecific Antibodies for the Treatment of Relapsed/Refractory (R/R) Follicular Lymphoma (FL) (0:00)
    • Clinical Data Available with Mosunetuzumab for R/R FL (1:54)
    • Clinical Data Available with Epcoritamab for R/R FL (4:54)
    • Clinical Data Available with Odronextamab for R/R FL (6:53)
    • Clinical Considerations in Selecting Among Available Bispecific Antibodies for R/R FL (8:34)
    • Practical Considerations in the Administration of Bispecific Antibodies (15:21)
    • The Role of Vaccinations in the Prevention of Infections for Patients Receiving Bispecific Antibodies (18:34)
    • Ongoing Clinical Trials Evaluating Bispecific Antibodies for FL (21:34)
    • Case: A man in his late 60s with refractory FL who received mosunetuzumab monotherapy (24:24)
    • Case: A woman in her late 50s with relapsed FL who received third-line epcoritamab monotherapy (30:14)
    • Case: A man in his late 80s with a long-standing history of FL who received odronextamab in combination with a second novel bispecific antibody (33:48)

    CME information and select publications
    Show more Show less
Show more Show less
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Therapy

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available